[Survival and recurrence in the multidisciplinary approach of colorectal cancer].
OBJECTIVE
Colorectal cancer is one of the most frequent causes of death in the general population. Our aim was to analyze our experience in the multidisciplinary approach of colorectal carcinoma during a three year period.


METHODS
Between January 1996 and December 1998, we studied prospectively 807 patients with colorectal cancer. The epidemiology, treatment and outcome(recurrence and survival) were analyzed. The minimum follow-up was 3 years.


RESULTS
There were 598 colon (65.5%) and 279 rectal (34.5%) tumors in all the series. Surgical treatment was elective in 84% and urgent in 16%, and was considered radical in 598 cases (74.1%). Chemotherapy or radiotherapy was administered in 49.6% and 18.3% patients, respectively. The overall 3-year survival was as follows: stage I 97.5%, stage II 90.6%, stage III 75.2%, and stage IV 12.6%. The 3-year free-disease survival was as follows: in colon cancer 97.8% for stage I, 87.3% for stage II, and 71.4% for stage III; and in rectal cancer 96.8% for stage I, 85.1% for stage II, and 75.4% for stage III. During the follow-up 124 patients (20.7%) developed recurrence: local (2.8%), systemic (15.9%) or both (2%). The three-year survival in operated patients with liver metastases was 61.9%.


CONCLUSIONS
We have observed adequate survival and recurrence rates which are the result are of systematic protocols established by a multidisciplinary team.
Martí-Ragué
Juan
J
Servicio de Cirugía General y Digestiva, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. dpares@vodafone.es
Parés
David
D
Biondo
Sebastiano
S
Navarro
Matilde
M
Figueras
Juan
J
de Oca
Javier
J
Pareja
Laura
L
Cambray
Maria
M
del Río
Carlos
C
Osorio
Alfonso
A
Novell
Valeri
V
Jaurrieta
Eduardo
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015179:Colorectal Neoplasms / Q000401:mortality* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016019:Survival Analysis
Supervivencia y recidiva en el tratamiento multidisciplinario del carcinoma colorrectal.